Clinical Safety

Vaccine Safety Insights: US and Australia COVID-19 Focus
Research & Development Vaccine Safety Insights: US and Australia COVID-19 Focus

In a world still grappling with the aftermath of a global health crisis that recorded over 700 million cases and 7 million deaths, the role of COVID-19 vaccines stands as a testament to human ingenuity and scientific progress. These vaccines, developed at an unprecedented pace through years of

Sugary Drinks Fuel Colorectal Cancer Spread to Liver
Research & Development Sugary Drinks Fuel Colorectal Cancer Spread to Liver

Imagine reaching for a refreshing soda on a hot day, unaware that this simple choice might play a role in accelerating a deadly disease, as recent research has spotlighted a troubling link between sugary drinks and the spread of colorectal cancer to the liver, a leading cause of mortality among

How Can AI Transform Patient Safety in U.S. Healthcare?
Research & Development How Can AI Transform Patient Safety in U.S. Healthcare?

In the sprawling landscape of U.S. healthcare, a silent crisis unfolds every day as hundreds of thousands of patients suffer preventable harm or even death due to medical errors, positioning patient safety as an urgent public health challenge that demands immediate attention. With medical errors

Bipartisan Backing Boosts Vaccine Industry Confidence
Research & Development Bipartisan Backing Boosts Vaccine Industry Confidence

The vaccine industry in the United States finds itself at a critical juncture, where an unprecedented level of bipartisan support offers a glimmer of hope amid swirling controversies, technological debates, and regulatory uncertainties that could shape its future trajectory. A recent poll conducted

Opterion Health Submits CTA for Revolutionary OPT101 Therapy
Research & Development Opterion Health Submits CTA for Revolutionary OPT101 Therapy

In a landscape where millions of patients with advanced chronic kidney disease (CKD) struggle with limited and often burdensome treatment options, a groundbreaking development has emerged to potentially transform their lives. Opterion Health AG, a clinical-stage biopharmaceutical company

Should Hepatitis B Vaccine for Newborns Be Delayed?
Research & Development Should Hepatitis B Vaccine for Newborns Be Delayed?

What if a single policy change could jeopardize decades of progress in safeguarding children from a silent, deadly virus, and what would be the consequences of such a shift? The debate over delaying the hepatitis B vaccine from birth to age 4 has erupted into a heated controversy, pitting public

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later